Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas

Also known as: Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB16479	Inbakicept	1 / 2	Terminated	1
DB00073	Rituximab	1 / 2	Terminated	1
DB17468	Odetiglucan	2	Completed	1
DB00073	Rituximab	2	Completed	1